glp-1 seattle VOL.U.LIFT™ 4D Skin Rebound Complex — Fine Line If you are hearing more

Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January

Achieve sustainable weight loss with a personalized compounded GLP-1 injection plan from Refills

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight - a substantial step up in...

From 4663 identified articles, 6 met the inclusion criteria, but only one was a randomized controlled trial

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month